Dexamethasone should not be given to people with a chronic subdural haematoma

Helen Saul; Deniz Gursul; Samantha Cassidy; Peter Hutchinson; Angelos Kolias

doi:10.1136/bmj.o1302

Dexamethasone should not be given to people with a chronic subdural haematoma

BMJ. 2022 Jun 10:377:o1302. doi: 10.1136/bmj.o1302.

Authors

Helen Saul¹, Deniz Gursul¹, Samantha Cassidy¹, Peter Hutchinson², Angelos Kolias²

Affiliations

¹ NIHR Centre for Engagement and Dissemination, Twickenham, UK.
² Addenbrooke's Hospital and University of Cambridge, UK.

PMID: 35688460
DOI: 10.1136/bmj.o1302

Abstract

The studyHutchinson P, Edlmann E, Bulters D, et al. Trial of dexamethasone for chronic subdural haematoma. N Engl J Med 2020;383:2616-27.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/dexamethasone-should-not-be-used-chronic-subdural-haematoma/.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

MeSH terms

Dexamethasone / adverse effects
Hematoma, Subdural, Chronic* / drug therapy
Humans

Substances

Dexamethasone